|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-13
|
$1,336,045
|
$160,325
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$58,774
|
$5,877
|
Merlino, Glenn
|
CCR (NCI)
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S1
|
$74,531
|
$3,727
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-25S2
|
$49,999
|
$2,500
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-25
|
$5,801,264
|
$290,063
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-06
|
$1,463,426
|
$43,903
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-26
|
$1
|
$0
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$224,566
|
$89,826
|
Fowler, Daniel
|
CCR (NCI)
|
|
|
U10 Full Member Application Affiliated with SWOG
|
5U10CA105409-10
|
$341,201
|
$3,412
|
Eng, Cathy
|
UT MD ANDERSON CANCER CTR
|
|
|
Transplant Models
|
ZIA BC 010957
|
$764,570
|
$764,570
|
Gress, Ronald
|
CCR (NCI)
|
|
|
Translating Novel Drug-Targetable Biomarkers to Treat Graft versus Host Disease
|
1R01CA168814-01A1
|
$329,962
|
$329,962
|
Paczesny, Sophie
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-29
|
$638,503
|
$638,503
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-25
|
$2,089,499
|
$250,740
|
Press, Oliver
|
FRED HUTCHINSON CAN RES CTR
|
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
5U10CA045809-25
|
$1,885,277
|
$75,411
|
FISCH, MICHAEL
|
UT MD ANDERSON CANCER CTR
|
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
3P50CA083639-14S1
|
$31,250
|
$1,875
|
BAST, ROBERT
|
UT MD ANDERSON CANCER CTR
|
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA083639-14
|
$2,082,690
|
$124,961
|
BAST, ROBERT
|
UT MD ANDERSON CANCER CTR
|
|
|
The Therapy of CML
|
5P01CA049639-23
|
$3,383,296
|
$439,828
|
CHAMPLIN, RICHARD
|
UT MD ANDERSON CANCER CTR
|
|
|
The synergistic effect of NOTCH, SALL4, and hydrogel on hematopoietic stem cells
|
1R21CA179629-01
|
$206,190
|
$206,190
|
Aguila, Jerell
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
|
The Genetics of Post-Transplant Relapse in Myeloid Malignancy
|
1R01CA175008-01A1
|
$365,200
|
$365,200
|
Radich, Jerald
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
ZIA SC 010288
|
$449,132
|
$224,566
|
Fowler, Daniel
|
CCR (NCI)
|
|
|
Th1/Th17 Cell Differentiation in GVHD and GVL
|
7R01CA143812-04
|
$293,729
|
$293,729
|
Yu, Xue-Zhong
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
TAS::75 0849::TAS Incremental Funding
|
261200800001E-51
|
$271,391,560
|
$2,470
|
Heimbrook, David
|
SAIC-FREDERICK, INC.
|
|
|
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
|
1K08CA169485-01A1
|
$171,372
|
$171,372
|
Chapuis, Aude
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Targeting dendritic cells for selective modulation of Graft-versus-Host Disease
|
ZIA BC 011320
|
$119,093
|
$119,093
|
Fry, Terry
|
CCR (NCI)
|
|
|
Targeted therapy of ALL with gene-modified central memory T cells
|
5R01CA136551-05
|
$508,741
|
$254,371
|
Riddell, Stanley
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-03
|
$298,427
|
$298,427
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
|
T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia
|
5R01CA141303-04
|
$298,935
|
$298,935
|
COOPER, LAURENCE
|
UT MD ANDERSON CANCER CTR
|
|
|
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
|
5R01CA154244-09
|
$365,317
|
$365,317
|
Korngold, Robert
|
HACKENSACK UNIVERSITY MEDICAL CENTER
|
|
|
SYNTHESES AND CELLULAR STUDIES OF NEW PHOTOSENSITIZERS FOR MEDICAL APPLICATIONS
|
5R01CA132861-05
|
$278,122
|
$69,531
|
Smith, Kevin
|
LOUISIANA STATE UNIV A&M COL BATON ROUGE
|
|
|
SWOG Community Clinical Oncology Program Research Base
|
7U10CA037429-29
|
$4,229,363
|
$42,294
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
SunCoast CCOP Research Base at the University of South Florida
|
5U10CA081920-12
|
$2,305,668
|
$46,113
|
KRISCHER, JEFFREY
|
UNIVERSITY OF SOUTH FLORIDA
|
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$317,388
|
$238,041
|
Tosato, Giovanna
|
CCR (NCI)
|
|
|
Sten Cell Gene Therapy of Breast Cancer
|
5R01CA136487-05
|
$295,150
|
$295,150
|
LIEBER, ANDRE
|
UNIVERSITY OF WASHINGTON
|
|
|
Stanford University Cancer Center
|
3P30CA124435-07S1
|
$75,000
|
$2,250
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
|
Stanford University Cancer Center
|
5P30CA124435-07
|
$2,890,663
|
$86,720
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
|
Southwest Oncology Group/University of California, Davis
|
5U10CA046441-26
|
$314,015
|
$3,140
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
|
Southwest Oncology Group U10 Member Site
|
5U10CA014028-40
|
$331,824
|
$3,318
|
FLAHERTY, LAWRENCE
|
WAYNE STATE UNIVERSITY
|
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-34S1
|
$429,287
|
$4,293
|
BLANKE, CHARLES
|
UNIVERSITY OF MICHIGAN
|
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-34
|
$12,219,352
|
$122,194
|
BLANKE, CHARLES
|
UNIVERSITY OF MICHIGAN
|
|
|
SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
|
5U10CA038926-28
|
$5,374,654
|
$53,747
|
LEBLANC, MICHAEL
|
FRED HUTCHINSON CAN RES CTR
|
|
|
SOUTHWEST ONCOLOGY GROUP CA13612
|
3U10CA013612-39S1
|
$240,587
|
$2,406
|
CRANMER, LEE
|
UNIVERSITY OF ARIZONA
|
|
|
Southwest Oncology Group
|
5U10CA046282-26
|
$338,795
|
$3,388
|
STIFF, PATRICK
|
LOYOLA UNIVERSITY CHICAGO
|
|
|
Southwest Oncology Group
|
5U10CA020319-37
|
$284,743
|
$2,847
|
GOODMAN, GARY
|
SWEDISH MEDICAL CENTER, FIRST HILL
|
|
|
Southwest Oncology Group
|
5U10CA027057-34
|
$401,056
|
$4,011
|
SCHOTT, ANNE
|
UNIVERSITY OF MICHIGAN
|
|
|
Southwest Oncology Group
|
5U10CA011083-46
|
$377,652
|
$3,777
|
FRIEDBERG, JONATHAN
|
UNIVERSITY OF ROCHESTER
|
|
|
Southwest Oncology Group
|
5U10CA058882-21
|
$337,210
|
$3,372
|
LENZ, HEINZ JOSEF
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Role of Setbp1 in leukemic stem cell self-renewal
|
5R01CA143193-04
|
$289,474
|
$144,737
|
Du, Yang
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
|
|
Role of noncoding RNA in Regulating GVHD
|
1R01CA173878-01A1
|
$322,663
|
$322,663
|
Reddy, Pavan
|
UNIVERSITY OF MICHIGAN
|
|
|
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development
|
6R21CA167238-02
|
$182,251
|
$182,251
|
RIVERA, AMARILIZ
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
|
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development
|
1R21CA167238-01A1
|
$25,000
|
$25,000
|
RIVERA, AMARILIZ
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
Total relevant funding to Bone Marrow Transplantation for this search: $48,031,801
|
